Clinical Trial

The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health

Recruiting
View on ClinicalTrials.gov →
Summary
Recently a dietary recommendation of 400 - 600 mg/ day has been proposed for the reduced risk of developing cardiovascular disease. Dietary flavanols can be obtained from the intake of foods such as tea, cocoa, wine, berries and apples. Incorporating Chardonnay Marc (the skins and seeds of Chardonnay grapes) into the diet can be an additional source of dietary flavanols. Like other flavanol-rich foods, Chardonnay Marc provides fiber and polysaccharides that may benefit gut health. This study seeks pilot data on the impact of the daily incorporation of Chardonnay Marc powder into the diet on markers of gut and cardiometabolic health.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06 -> 2027-06 2026-08-08
minor Completion pushed: 2026-06 -> 2027-06 2026-08-08
Trial Details
NCT Number NCT06476795
Lead Sponsor University of California, Davis
Conditions Cardiovascular Diseases, Adiposity, Cardiometabolic Syndrome
Enrollment 5 participants
Start Date 2024-06-01
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-08-07